MANZF yields 3544.84% · PFE yields 6.13%● Live data
📍 MANZF pulled ahead of the other in Year 1
Combined, MANZF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MANZF + PFE for your $10,000?
Manz AG engages in the manufacture and sale of high-tech equipment in Germany, the United States, Taiwan, rest of Europe, China, and internationally. The company operates in five segments: Solar, Electronics, Energy Storage, Contract Manufacturing, and Service. The Solar segment provides system solutions for thin-film solar modules and CIGS thin-film technology. The Electronics segment offers production, assembly, and handling systems for the manufacture of flat screen displays, touch sensors, printed circuit boards, chip carriers, smartphones, tablet computers, laptops, wearables, and other consumer electronics; and automated assembly solutions for the automotive industry. The Energy Storage segment offers production, assembly, and handling equipment for lithium-ion battery cells, modules, and systems, as well as for capacitors for the manufacture of consumer electronics, power electronics, and other components of electrical powertrain. The Contract Manufacturing segment provides contract manufacturing services for equipment manufacturing, parts production, and assembly works for range of industries. The Service segment offers after-sales services, such as repair and maintenance, or conversion and upgrade services for machines and assemblies. Manz AG also provides simulation and factory planning, process and prototype development, and customer training services. The company was formerly known as Manz Automation AG and changed its name to Manz AG in June 2011. Manz AG was founded in 1987 and is based in Reutlingen, Germany.
Full MANZF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.